Articles

The Paris Olympics boasts many firsts. It featured the first opening ceremony not held in a stadium, it’s the first Olympics with full gender parity — and it’s the first Games to see extensive use of artificial intelligence.

A blood test has greater success than doctors in determining whether someone has memory loss due to Alzheimer’s disease, a new study found.

Tilray’s bet on craft beers appears to be paying off.

Last week, Amazon, Disney and NBC landed more than a decade’s worth of broadcast rights for NBA games starting late next year — at the expense of TNT. But analysts at MoffettNathanson on Monday suggested that even the winners in the deal faced big sacrifices.

Consumer advocates are concerned that companies want to use personal data to optimize pricing and boost sales.

Elon Musk’s endorsement of Donald Trump for president was the capstone in a political transformation of a figure who once raised money for Barack Obama and who took heat from Fox News for borrowing from the Department of Energy to fund the manufacture of luxury electric cars.

The Treasury Department said Monday it expects to borrow $740 billion in the third quarter, which is $106 billion less than estimated three months ago.

The U.S. initial public offering market has raised $23.2 billion in proceeds in the year to date, surpassing the $19.4 billion raised for all of 2023 — with five months still to go.

It’s the first such blood test to receive regulatory approval in the U.S. and the first that meets the requirements for Medicare coverage.

When there’s bad blood over an inheritance, you can challenge the trustee — but try talking first.

The rally in U.S. stock market might be due for a downshift in coming months as seasonal trends bring elevated near-term risk to the S&P 500, according to BofA Global Research.

Don’t bet against the American consumer, an old saying goes. That wisdom was borne out this spring and summer, when wagering against them would have been a mistake.